1.22
17.31%
0.18
시간 외 거래:
1.15
-0.07
-5.74%
Artelo Biosciences Inc (ARTL) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
기간 종료일 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
Revenues |
-
|
- | - | - | - |
Operating Expenses
|
20.09%
2.589
|
3.24 | 2.614 | 1.784 | 2.292 |
Operating Income/Loss |
20.09%
-2.589
|
-3.24 | -2.614 | -1.784 | -2.292 |
Nonoperating Income/Loss |
36.53%
0.106
|
0.167 | 0.165 | 0.185 | 0.124 |
Income/Loss From Continuing Operations Before Tax |
83.99%
-2.483
|
-15.51 | -2.449 | -1.599 | -2.168 |
Income Tax Expense/Benefit |
-
|
- | - | - | - |
Income/Loss From Continuing Operations After Tax |
83.99%
-2.483
|
-15.51 | -2.449 | -1.599 | -2.168 |
Net Income/Loss
|
83.99%
-2.483
|
-15.51 | -2.449 | -1.599 | -2.168 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
100.00%
-
|
-12.43 | - | - | - |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
자본화:
|
볼륨(24시간):